Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$239.72M$239.72Mderived+24.5% vs Q4 2023 Net Income$35.22M$35.22Mderived+138.6% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$203,730,000+23.9% Operating Incomederived$31,884,000+242.9% Operating Cash Flowderived$69,181,000+300.7% Free Cash Flowderived$62,154,000+573.1% Margins · derivedGross margin85.0%−0.4 pt vs Q4 2023
Operating margin13.3%+8.5 pt vs Q4 2023
Net margin14.7%+7.0 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 10, 2025 · 41 d after period end